Black Diamond Therapeutics Inc BDTX:NASDAQ

Last Price$6.00NASDAQ Previous Close - Last Trade as of 4:00PM ET 12/03/21
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$5.90 (2)
Ask (Size)$6.36 (2)
Day Low / HighN/A - N/A
Volume225.9 K
 

Read more news Recent News

-- Earnings Flash (BDTX) BLACK DIAMOND THERAPEUTICS Reports Q3 Loss $-0.97
7:45AM ET 11/08/2021 MT Newswires

...

Stifel Starts Black Diamond Therapeutics at Hold With $10 Price Target
7:28AM ET 9/30/2021 MT Newswires

Black Diamond Therapeutics (BDTX) has an average investment rating of buy and price targets ranging from $10 to $53, according to analysts polled by...

Black Diamond Therapeutics Partners With OpenEye Scientific to Accelerate Drug Discovery
10:08AM ET 9/21/2021 MT Newswires

Black Diamond Therapeutics (BDTX) will incorporate OpenEye Scientific's Orion molecular design platform into its mutation-allostery-pharmacology drug...

--Wedbush Lowers PT for Black Diamond Therapeutics to $22 From $48 Following BDTX-189 Data, Reiterates Outperform Rating
3:32PM ET 8/17/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

View all Commentary and Analysis

ASCO 2021: A Plethora Of Cancer Therapeutic Investment Ideas
1:32AM ET 6/02/2021 Seeking Alpha

Wall Street Breakfast: What Moved Markets
8:31AM ET 5/22/2021 Seeking Alpha

Black Diamond Therapeutics (BDTX) Investor Presentation - Slideshow
1:12PM ET 4/01/2021 Seeking Alpha

Wall Street Breakfast: The Week Ahead
7:08AM ET 3/28/2021 Seeking Alpha

Company Profile

Business Description
Number of EmployeesN/A
Recent SEC Filing11/29/20213

Company Highlights

Price Open$6.26
Previous Close$6.22
52 Week Range$5.86 - 37.76
Market Capitalization$217.4 M
Shares Outstanding36.2 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement03/24/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$3.38
Beta vs. S&P 500N/A
RevenueN/A
Net Profit MarginN/A
Return on Equity-46.24%

Analyst Ratings as of 09/28/2021

Buy
7
Overweight
0
Hold
1
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset